Omnigence Asset Management
Home
About
Team
Data Science
Insights & News
Contact
Farmland
OVERVIEW
TEAM
UPDATES

Veripath Partners: Our Canadian farmland investment fund focuses on non-operated row crop farmland with productivity pricing discounts, positive productivity trends and low productivity volatility. Veripath provides consistent returns with infrequent drawdowns, low return volatility and can be an effective public equity replacement in traditional portfolios.

Private Equity
OVERVIEW
TEAM
UPDATES
PORTFOLIO

Arvore Partners: Our private equity vertical invests in the lower market where cashflow can be acquired at compelling multiples, then serially consolidated in selected verticals to drive exits. Arvore provides monthly distributions and recurring equity optionality within an evergreen offering.

Multi-Asset
OVERVIEW
TEAM
UPDATES

Genivent Partners: Our multi-asset vertical opportunistically invests in Omnigence partners funds’ secondaries and GP holdings. Genivent acts as a dedicated liquidity sleeve for investors seeking intra-hold period liquidity.

OVERVIEW
TEAM
UPDATES

Veripath Partners: Our Canadian farmland investment fund focuses on non-operated row crop farmland with productivity pricing discounts, positive productivity trends and low productivity volatility. Veripath provides consistent returns with infrequent drawdowns, low return volatility and can be an effective public equity replacement in traditional portfolios.

OVERVIEW
TEAM
UPDATES
PORTFOLIO

Arvore Partners: Our private equity vertical invests in the lower market where cashflow can be acquired at compelling multiples, then serially consolidated in selected verticals to drive exits. Arvore provides monthly distributions and recurring equity optionality within an evergreen offering.

OVERVIEW
TEAM
UPDATES

Genivent Partners: Our multi-asset vertical opportunistically invests in Omnigence partners funds’ secondaries and GP holdings. Genivent acts as a dedicated liquidity sleeve for investors seeking intra-hold period liquidity.

Home
About
Team
Data Science
Insights & News
Contact
Navigation menu closed
April 6, 2026

ConcentrationRiskinMega-BuyoutFundsandtheCaseforMiddle-MarketPE

Private equity capital has increasingly concentrated in mega-buyout funds, driven by investor preferences for scale, brand recognition, and operational simplicity. While these large funds offer institutional familiarity, their size introduces structural challenges that may limit return potential.

As funds grow, the universe of viable deals shrinks. Mega-buyout funds must deploy billions of dollars across a small number of large companies, often competing aggressively in auction processes that push entry valuations to record levels. Median purchase multiples reached 11.8× EBITDA in 2025, raising the bar for value creation and compressing margins of safety.

Performance data increasingly reflects these structural pressures. Between the 2019 and 2021 vintages, the fifteen largest buyout funds delivered a median IRR of 10.0%, compared with 16.3% for the rest of the market. At the same time, exit bottlenecks have extended holding periods to 6.5–8.5 years and created a backlog of more than 16,000 PE-backed companies globally.

Middle-market private equity offers a contrasting dynamic. With a broader universe of companies, lower entry multiples, and greater opportunity for operational improvement, the segment continues to demonstrate stronger EBITDA growth and greater performance dispersion.

For advisors and allocators, the implication is clear: private equity allocations should not default to the largest funds. A more thoughtful approach considers fund size, vintage diversification, and manager selection in order to capture the true illiquidity premium private markets are intended to deliver.

View Full Report

LegalPrivacy Policy
AboutTeamData ScienceInsights & NewsContact
AI Index